XML 77 R67.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATING FINANCIAL INFORMATION (Consolidating Statements of Cash Flows) (Details) (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Condensed Financial Statements, Captions [Line Items]      
Net income $ 52,027,000 $ 87,145,000 $ 21,627,000
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Depreciation and amortization 2,140,000    
Provision for credit losses 4,265,000 20,148,000 11,305,000
Unrealized loss (gain) on trading securities 1,054,000    
Equity in earnings of unconsolidated entities (5,389,000) (4,083,000) (9,507,000)
Distributions from unconsolidated entities 4,647,000    
Impairment charge on loan investment 214,000    
Gain on sale of loans and investment securities, net (6,293,000)    
Gain on sale of assets (1,734,000)    
Deferred income tax provision 25,000    
Equity-based compensation issued 1,257,000    
Equity-based compensation received 0    
Trading securities purchases and sales, net 10,287,000    
Loss from discontinued operations 2,000 44,000 2,222,000
Changes in operating assets and liabilities 2,840,000    
Net cash used in operating activities (90,878,000) (7,981,000) 17,065,000
Capital expenditures (2,730,000)    
Payments received on real estate loans and real estate 2,049,000    
Investments in unconsolidated real estate entities (1,545,000)    
Principal payments received on leases and loans 17,000    
Principal payments and proceeds from sales received by consolidated VIE - RSO 1,348,597,000    
Increase in borrowings 2,001,000    
Increase in restricted cash of consolidated VIE - RSO 22,248,000    
Other investing activity of consolidated VIE - RSO (30,446,000)    
Net cash provided by (used in) investing activities 473,038,000 115,220,000 (485,988,000)
Principal payments on borrowings (2,486,000)    
Net (repayments) borrowings of debt by consolidated VIE - RSO (420,107,000)    
Dividends paid (1,988,000)    
Dividends paid on common stock by consolidated VIE - RSO (91,255,000)    
Proceeds from issuance of common stock 1,252,000    
Repurchase of common stock (4,607,000)    
Other 67,000    
Net cash (used in) provided by financing activities (373,835,000) (106,866,000) 468,839,000
Operating activities (371,000) (1,277,000) (1,643,000)
Net cash used in discontinued operations (371,000) (1,277,000) (1,643,000)
Cash and Cash Equivalents, Period Increase (Decrease) 7,954,000 (904,000) (1,727,000)
Cash 19,853,000 11,899,000 12,803,000
Consolidation, Eliminations [Member]
     
Condensed Financial Statements, Captions [Line Items]      
Net income (2,616,000)    
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Depreciation and amortization 0    
Provision for credit losses 0    
Unrealized loss (gain) on trading securities 33,000    
Equity in earnings of unconsolidated entities 0    
Distributions from unconsolidated entities 0    
Impairment charge on loan investment 0    
Gain on sale of loans and investment securities, net 230,000    
Gain on sale of assets 0    
Deferred income tax provision 0    
Equity-based compensation issued 0    
Equity-based compensation received 1,138,000    
Trading securities purchases and sales, net (230,000)    
Loss from discontinued operations 0    
Changes in operating assets and liabilities 205,000    
Net cash used in operating activities (2,436,000)    
Capital expenditures 0    
Payments received on real estate loans and real estate 0    
Investments in unconsolidated real estate entities 0    
Principal payments received on leases and loans 0    
Purchase of loans and investments 0    
Principal payments and proceeds from sales received by consolidated VIE - RSO 0    
Increase in borrowings 0    
Increase in restricted cash of consolidated VIE - RSO 0    
Other investing activity of consolidated VIE - RSO (593,000)    
Net cash provided by (used in) investing activities (593,000)    
Principal payments on borrowings 621,000    
Net (repayments) borrowings of debt by consolidated VIE - RSO 0    
Dividends paid 0    
Dividends paid on common stock by consolidated VIE - RSO 2,203,000    
Proceeds from issuance of common stock 0    
Repurchase of common stock 0    
Other 205,000    
Net cash (used in) provided by financing activities 3,029,000    
Operating activities 0    
Net cash used in discontinued operations 0    
Cash and Cash Equivalents, Period Increase (Decrease) 0    
Cash 0 0  
Reportable Legal Entities [Member]
     
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Net cash used in operating activities (155,024,000)    
RAI [Member]
     
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Depreciation and amortization 2,140,000 2,338,000 17,044,000
Provision for credit losses 4,265,000 20,148,000 12,104,000
Unrealized loss (gain) on trading securities 1,054,000 (1,272,000) 0
Equity in earnings of unconsolidated entities (5,389,000) (4,083,000) (9,507,000)
Distributions from unconsolidated entities 4,647,000 3,311,000 5,022,000
Gain on sale of loans and investment securities, net (6,293,000) (1,221,000) (321,000)
Gain on sale of assets (1,734,000) (915,000) (196,000)
Deferred income tax provision 25,000 11,836,000 (3,211,000)
Equity-based compensation issued 1,257,000 993,000 2,242,000
Trading securities purchases and sales, net 10,287,000 (2,876,000) 0
Loss from discontinued operations 2,000 44,000 2,222,000
Changes in operating assets and liabilities 2,840,000 (4,983,000) (6,159,000)
Capital expenditures (2,730,000) (196,000) (1,233,000)
Payments received on real estate loans and real estate 2,049,000 888,000 18,037,000
Investments in unconsolidated real estate entities (1,545,000) (2,493,000) (2,215,000)
Principal payments received on leases and loans 17,000 15,000 38,087,000
Purchase of loans and investments (3,213,000) (2,597,000) (600,000)
Increase in borrowings 2,001,000 0 233,888,000
Principal payments on borrowings (2,486,000) (5,715,000) (177,431,000)
Dividends paid (1,988,000) (2,334,000) (2,264,000)
Proceeds from issuance of common stock 1,252,000 2,131,000 1,914,000
Repurchase of common stock (4,607,000) (2,463,000) (1,180,000)
Other 67,000 (203,000) (7,342,000)
Cash 19,853,000 11,899,000  
RAI [Member] | Consolidation, Eliminations [Member]
     
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Cash 0    
RAI [Member] | Reportable Legal Entities [Member]
     
Condensed Financial Statements, Captions [Line Items]      
Net income 8,190,000    
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Depreciation and amortization 2,140,000    
Provision for credit losses 4,265,000 20,148,000 11,305,000
Unrealized loss (gain) on trading securities 1,021,000    
Equity in earnings of unconsolidated entities (5,389,000) (4,083,000) (9,507,000)
Distributions from unconsolidated entities 4,647,000    
Impairment charge on loan investment 214,000    
Gain on sale of loans and investment securities, net (6,523,000)    
Gain on sale of assets (1,734,000)    
Deferred income tax provision 25,000    
Equity-based compensation issued 1,257,000    
Equity-based compensation received (1,138,000)    
Trading securities purchases and sales, net 10,517,000    
Loss from discontinued operations 2,000    
Changes in operating assets and liabilities 2,635,000    
Net cash used in operating activities 20,129,000    
Capital expenditures (2,730,000)    
Payments received on real estate loans and real estate 2,049,000    
Investments in unconsolidated real estate entities (1,545,000)    
Principal payments received on leases and loans 17,000    
Purchase of loans and investments (3,213,000)    
Principal payments and proceeds from sales received by consolidated VIE - RSO 0    
Increase in borrowings 2,001,000    
Increase in restricted cash of consolidated VIE - RSO 0    
Other investing activity of consolidated VIE - RSO 0    
Net cash provided by (used in) investing activities (5,422,000)    
Principal payments on borrowings (3,107,000)    
Net (repayments) borrowings of debt by consolidated VIE - RSO 0    
Dividends paid (1,988,000)    
Dividends paid on common stock by consolidated VIE - RSO 0    
Proceeds from issuance of common stock 1,252,000    
Repurchase of common stock (4,607,000)    
Other 67,000    
Net cash (used in) provided by financing activities (6,382,000)    
Operating activities (371,000)    
Net cash used in discontinued operations (371,000)    
Cash and Cash Equivalents, Period Increase (Decrease) 7,954,000    
Cash 19,853,000 11,899,000  
RSO [Member]
     
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Net cash used in operating activities (156,220,000)    
Purchase of loans and investments (861,939,000) (769,762,000) (1,072,132,000)
Principal payments and proceeds from sales received by consolidated VIE - RSO 1,348,597,000 822,476,000 663,663,000
Increase in restricted cash of consolidated VIE - RSO 22,248,000 50,756,000 31,014,000
Other investing activity of consolidated VIE - RSO (30,446,000) (1,782,000) (45,795,000)
Net (repayments) borrowings of debt by consolidated VIE - RSO (420,107,000) (192,783,000) 365,143,000
Dividends paid on common stock by consolidated VIE - RSO (91,255,000) (71,876,000) (67,415,000)
Proceeds from issuance of common stock 189,991,000 171,056,000 129,911,000
Other (46,703,000) (4,679,000) (6,385,000)
RSO [Member] | Consolidation, Eliminations [Member]
     
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Net cash used in operating activities (1,196,000)    
RSO [Member] | Reportable Legal Entities [Member]
     
Condensed Financial Statements, Captions [Line Items]      
Net income 46,453,000    
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Depreciation and amortization 0    
Provision for credit losses 0 0 0
Unrealized loss (gain) on trading securities 0    
Equity in earnings of unconsolidated entities 0 0 0
Distributions from unconsolidated entities 0    
Impairment charge on loan investment 0    
Gain on sale of loans and investment securities, net 0    
Gain on sale of assets 0    
Deferred income tax provision 0    
Equity-based compensation issued 0    
Equity-based compensation received 0    
Trading securities purchases and sales, net 0    
Loss from discontinued operations 0    
Changes in operating assets and liabilities 0    
Net cash used in operating activities (108,571,000)    
Capital expenditures 0    
Payments received on real estate loans and real estate 0    
Investments in unconsolidated real estate entities 0    
Principal payments received on leases and loans 0    
Purchase of loans and investments (861,939,000)    
Principal payments and proceeds from sales received by consolidated VIE - RSO 1,348,597,000    
Increase in borrowings 0    
Increase in restricted cash of consolidated VIE - RSO 22,248,000    
Other investing activity of consolidated VIE - RSO (29,853,000)    
Net cash provided by (used in) investing activities 479,053,000    
Principal payments on borrowings 0    
Net (repayments) borrowings of debt by consolidated VIE - RSO (420,107,000)    
Dividends paid 0    
Dividends paid on common stock by consolidated VIE - RSO (93,458,000)    
Proceeds from issuance of common stock 189,991,000    
Repurchase of common stock 0    
Other (46,908,000)    
Net cash (used in) provided by financing activities (370,482,000)    
Operating activities 0    
Net cash used in discontinued operations 0    
Cash and Cash Equivalents, Period Increase (Decrease) 0    
Cash $ 0 $ 0